Clinical Trial Update: Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision [NA]

View source ↗

Summary

This clinical trial update indicates a completed study comparing Triamcinolone and Bevacizumab for central retinal vein occlusion with poor vision.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion

Drugs mentioned

• Bevacizumab (bevacizumab)
• Triamcinolone (triamcinolone)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Central Retinal Vein Occlusion With 20/200 or Worse Visual Acuity | NA | Status: COMPLETED